###begin article-title 0
###xml 21 26 <span type="species:ncbi:9606">Human</span>
Differential Role of Human Choline Kinase alpha and beta Enzymes in Lipid Metabolism: Implications in Cancer Onset and Treatment
###end article-title 0
###begin p 1
Conceived and designed the experiments: DGO ARdM JCL. Performed the experiments: DGO MAR FVM JSE. Analyzed the data: DGO ARdM. Contributed reagents/materials/analysis tools: MGB. Wrote the paper: DGO JCL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 472 477 <span type="species:ncbi:9606">human</span>
The Kennedy pathway generates phosphocoline and phosphoethanolamine through its two branches. Choline Kinase (ChoK) is the first enzyme of the Kennedy branch of synthesis of phosphocholine, the major component of the plasma membrane. ChoK family of proteins is composed by ChoKalpha and ChoKbeta isoforms, the first one with two different variants of splicing. Recently ChoKalpha has been implicated in the carcinogenic process, since it is over-expressed in a variety of human cancers. However, no evidence for a role of ChoKbeta in carcinogenesis has been reported.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 579 586 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 757 765 729 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 790 797 762 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1060 1067 1025 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Here we compare the in vitro and in vivo properties of ChoKalpha1 and ChoKbeta in lipid metabolism, and their potential role in carcinogenesis. Both ChoKalpha1 and ChoKbeta showed choline and ethanolamine kinase activities when assayed in cell extracts, though with different affinity for their substrates. However, they behave differentially when overexpressed in whole cells. Whereas ChoKbeta display an ethanolamine kinase role, ChoKalpha1 present a dual choline/ethanolamine kinase role, suggesting the involvement of each ChoK isoform in distinct biochemical pathways under in vivo conditions. In addition, while overexpression of ChoKalpha1 is oncogenic when overexpressed in HEK293T or MDCK cells, ChoKbeta overexpression is not sufficient to induce in vitro cell transformation nor in vivo tumor growth. Furthermore, a significant upregulation of ChoKalpha1 mRNA levels in a panel of breast and lung cancer cell lines was found, but no changes in ChoKbeta mRNA levels were observed. Finally, MN58b, a previously described potent inhibitor of ChoK with in vivo antitumoral activity, shows more than 20-fold higher efficiency towards ChoKalpha1 than ChoKbeta.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
###xml 169 174 <span type="species:ncbi:9606">human</span>
This study represents the first evidence of the distinct metabolic role of ChoKalpha and ChoKbeta isoforms, suggesting different physiological roles and implications in human carcinogenesis. These findings constitute a step forward in the design of an antitumoral strategy based on ChoK inhibition.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 158 162 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHKA</italic>
###xml 167 171 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHKB</italic>
###xml 339 342 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 631 634 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 724 727 687 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal1">[2]</xref>
###xml 858 861 821 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal1">[2]</xref>
###xml 1021 1024 984 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 1026 1029 989 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Uchida1">[3]</xref>
###xml 1030 1033 993 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama2">[5]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human choline kinase alpha (ChoKalpha) and beta (ChoKbeta) are members of the choline kinase family. In mammals this family is encoded by two separate genes, CHKA and CHKB, resulting in three different proteins with a choline/ethanolamine kinase (ChoK/EtnK) domain: ChoKalpha1 (NP_001268), ChoKalpha2 (NP_997634) and ChoKbeta1 (NP_005189) [1]. ChoKalpha1 differs from ChoKalpha2 in only an extra stretch of 18 amino acids, while ChoKbeta differs from ChoKalpha1 and ChoKalpha2 in approximately 40%. The presence of the ChoK/EtnK domain confers the capacity to catalyze the phosphorylation of choline (Cho) to phosphocholine (PCho) [1]. This constitutes the first step in the biosynthesis pathway of phosphatidylcholine (PC) [2]. PC is the major phospholipid in eukaryotic membranes and plays a critical role in membrane structure and also in cell signalling [2]. ChoK enzymes could be implicated also in the synthesis of phosphatidylethanolamine (PE), using as substrate ethanolamine to render phosphoethanolamine (PEtn) [1], [3]-[5].
###end p 9
###begin p 10
###xml 61 64 61 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Malito1">[6]</xref>
###xml 66 69 66 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Zhou1">[7]</xref>
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama3">[8]</xref>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 511 514 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama3">[8]</xref>
Previous studies suggest that ChoK acts as a dimeric protein [6], [7] and the proportion of the different homo- or hetero- dimer population has been proposed to be tissue-specific [8]. Furthermore, the combination between choline kinase isoforms results in a different level of ChoK activity in vitro under cell-free systems conditions. Thus, the alpha/alpha homodimer is the most active choline kinase form, the beta/beta homodimer the less active, and the alpha/beta heterodimer has an intermediate phenotype [8].
###end p 10
###begin p 11
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Carnero1">[9]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez1">[11]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Cuadrado1">[12]</xref>
###xml 450 453 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHOA</italic>
###xml 539 543 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina1">[13]</xref>
###xml 544 548 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal2">[16]</xref>
###xml 659 663 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Griffin1">[17]</xref>
###xml 665 669 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Negendank1">[18]</xref>
###xml 869 873 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aboagye1">[19]</xref>
###xml 874 878 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Spadaro1">[25]</xref>
###xml 1102 1106 1098 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Bell1">[26]</xref>
###xml 386 392 <span type="species:ncbi:10090">murine</span>
###xml 776 784 <span type="species:ncbi:9606">patients</span>
The specific phospholipase D-driven hydrolysis of PC generates choline and signal transduction metabolites such as PA (phosphatidic acid), and its derivatives LPA (lysophosphatidic acid) and DAG (diacylglycerol), that are important in mitogenesis and cellular transformation [9]-[11]. Choline gets further converted by ChoK into PCho, an stable metabolite able to induce mitogenesis in murine fibroblasts [12]. In addition, several oncogenes such as RAS or RHOA increase ChoKalpha activity resulting in higher intracellular levels of PCho [13]-[16]. Magnetic resonance spectroscopy (MRS) studies have revealed abnormal phospholipid metabolism in cancer cells [17], [18]. Furthermore, high levels of PCho have been found in tumoral cells as well as in tumour samples of cancer patients compared with the normal counterparts in breast, prostate, brain and ovarian cancer [19]-[25]. The increase in phosphoethanolamine has been also reported in transformed cells or tumor samples using MRS, although it contributes to a much lesser extent, compared with the increase of PCho, to the phosphomonoester peak [26].
###end p 11
###begin p 12
###xml 223 227 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina3">[27]</xref>
###xml 228 232 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina6">[30]</xref>
###xml 346 350 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 488 492 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina6">[30]</xref>
###xml 631 635 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Eliyahu1">[21]</xref>
###xml 865 869 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Teichert1">[31]</xref>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
The implication of ChoKalpha in cell growth, proliferation, initiation and progression of cancer is well documented. ChoKalpha is overexpressed in some of the most common cancers, such as breast, lung, colorectal, prostate [27]-[30] and bladder (unpublished observations). Furthermore, it has oncogenic activity when overexpressed in human cells [15]. Increased ChoKalpha mRNA levels have been recently described as an independent prognostic marker in non small cell lung cancer patients [30]. Also, human breast cancer cell lines show upregulation of ChoKalpha but not ChoKbeta, when compared with normal mammary epithelial cells [21]. In that sense, it has been recently reported that in the prostate tumor mouse model (TRAMP), using IHQ immunodetection of ChoKbeta, a low level expression of ChoKbeta was found in tumoral samples compared with wild type tissues [31].
###end p 12
###begin p 13
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-GomezdelPulgar1">[32]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aznar2">[35]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba1">[14]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina7">[36]</xref>
###xml 334 338 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 340 344 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina5">[29]</xref>
The implication of members of the Rho GTPase family in cancer onset and progression has been extensively described [32]-[35]. Evidence that ChoK is involved in malignant transformation along with Ras and RhoA has been provided [14], [15], [36]. Moreover, the activity of ChoKalpha is modulated by known effectors of both Ras and RhoA [15], [29].
###end p 13
###begin p 14
###xml 90 93 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal1">[2]</xref>
###xml 353 357 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba1">[14]</xref>
###xml 359 363 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba2">[37]</xref>
###xml 364 368 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez4">[40]</xref>
###xml 332 341 <span type="species:ncbi:10090">nude mice</span>
Pharmacological inhibition of ChoKalpha has been proposed as a novel antitumoral strategy [2]. A strong support to this strategy is based on the use of MN58b, a well-characterized ChoKalpha inhibitor, which displays a potent antiproliferative effect in several tumoral cell lines in vitro, and a strong reduction of tumor growth in nude mice xenografts [14], [37]-[40].
###end p 14
###begin p 15
We have compared the biochemical and biological properties of ChoKalpha and ChoKbeta, and demonstrate that besides their homology, the latter is not able to induce cell transformation in HEK293T or MDCK cells. Moreover, we suggest differential behaviour between alpha and beta isoforms in phospholipids metabolism. Finally, the antitumoral properties of MN58b can be attributed to its specific inhibition of ChoKalpha. The implications of these findings are discussed.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Characterization of enzymatic properties of ChoKalpha1 and ChoKbeta isoforms
###end title 17
###begin p 18
###xml 228 231 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 233 236 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Porter1">[4]</xref>
###xml 238 242 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Ishidate1">[41]</xref>
###xml 243 247 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Uchida2">[43]</xref>
###xml 306 314 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 670 679 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g001">Figure 1a</xref>
###xml 920 929 899 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g001">Figure 1b</xref>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 529 534 <span type="species:ncbi:9606">human</span>
The activity of both choline kinase isoforms, ChoKalpha1 and ChoKbeta, has been described previously in different mammalian tissues, however their choline kinase and/or ethanolamine kinase activities are not fully characterized [1], [4], [41]-[43]. Thus, we first carried out a comparative analysis of the in vitro kinase activity of the two human ChoKalpha1 and ChoKbeta isoforms, regarding their ability to phosphorylate choline and ethanolamine. HEK293T cells were transfected with appropriate expression vectors carrying the human CHKA or CHKB genes or an empty vector, and tested for ChoK and EtnK activity. Expression levels achieved were checked by Western Blot (Figure 1a), and the relative enzymatic activity from cell extracts estimated. Both ChoKalpha1 and ChoKbeta displayed choline and ethanolamine kinase activities under these experimental conditions, but the rate of conversion was apparently different (Figure 1b).
###end p 18
###begin title 19
Characterization of choline and ethanolamine kinase activity of ChoKalpha1 and Chokbeta1 in HEK293T cells.
###end title 19
###begin p 20
###xml 148 150 141 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 294 299 280 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, C)</bold>
###xml 464 466 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 479 481 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 69 74 <span type="species:ncbi:9606">human</span>
HEK293T cells were transfected with eukaryotic expression vectors of human ChoKalpha1 and ChoKbeta1 gene. pCDNA3b empty vector was used as control. A) Overexpression of ChoKalpha1 and ChoKbeta1 in HEK293T cells detected by Western Blot. GAPDH detection was used as control of expression level. B, C) In vitro ChoK (B) and EtnK (C) activity of choline kinase alpha1 and beta1 isoforms in cell-free extracts of HEK293T transfected cells. Percentage of conversion of 14C-choline or 14C-ethanolamine to the phosphorylated product is represented. The experiment was performed in duplicate samples, repeated 4 times, and mean+/-SEM values from all experiments estimated.
###end p 20
###begin p 21
###xml 129 145 118 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 236 244 218 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 383 390 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007819-t001">Table 1</xref>
###xml 129 145 <span type="species:ncbi:562">Escherichia coli</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
We further analyze ChoK and EtnK kinetic activities for ChoKalpha1 and ChoKbeta isoforms using the recombinant enzymes. DH5alpha Escherichia coli were transformed with the gene encoding for human ChoKalpha1 or ChoKbeta and an enzymatic in vitro assay for either ChoK or EtnK activities performed. Michaelis constants (Km) for each isoform for the different substrates were obtained (Table 1). ChoKbeta showed a Km for choline 2.8 times higher than ChoKalpha1. By contrast, the Km of ChoKbeta for ethanolamine was lower than ChoKalpha1. These results suggest that in cell-free systems choline is a better substrate for ChoKalpha1 (2.85 fold) than ChoKbeta, whereas ethanolamine is a better substrate for ChoKbeta (5.83 fold) than ChoKalpha1.
###end p 21
###begin title 22
Michaelis constant (Km) of ChoKalpha and beta isoforms for choline and ethanolamine.
###end title 22
###begin p 23
Data are represented in milliMolar.
###end p 23
###begin p 24
Referenced to the lowest Km.
###end p 24
###begin p 25
###xml 206 226 206 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
Km of the different isoforms of ChoK for each substrate is indicated in each case. The results were obtained from four independent experiments using the logarithmic Michaelis-Menten formula as described in Material and Methods.
###end p 25
###begin title 26
ChoK isoforms are differentially regulated by Ras and Rho GTPases
###end title 26
###begin p 27
###xml 65 69 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 71 75 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina4">[28]</xref>
###xml 271 279 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 405 412 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g002">Fig. 2a</xref>
###xml 462 470 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g002">Figure 2</xref>
###xml 761 775 740 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g002">Fig. 2b and 2c</xref>
Since Ras and RhoA GTPases are upstream regulators of ChoKalpha1 [15], [28], some of the most studied proteins of the small GTPase family including H-Ras, and the Rho-family members RhoA and Cdc42 were tested as potential upstream modulators of ChoKbeta. To that end, an in vitro ChoK and EtnK activity assay was performed in HEK293T cells transfected with the constitutive active mutants of each GTPase (Fig. 2a) and either ChoKalpha1 and ChoKbeta. As shown in Figure 2, none of the GTPases tested were able to significantly increase choline or ethanolamine kinase activity of ChoKbeta. By contrast, under similar conditions, Ras and RhoA were able to induce a statistically significant change in the activation of both ChoK and EtnK activities of ChoKalpha1 (Fig. 2b and 2c).
###end p 27
###begin title 28
Differential activation of choline kinase alpha1 and beta1 isoforms by Ras and Rho GTPases.
###end title 28
###begin p 29
###xml 110 118 110 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 145 147 145 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 425 427 418 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 432 434 425 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 434 442 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 587 589 573 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 594 596 580 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E)</bold>
###xml 596 604 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
Choline kinase isoforms were expressed alone or in combination with the indicated Ras and Rho GTPases and the in vitro ChoK activity determined. A) Analysis of ectopic expression by Western Blot in HEK293T transfected cell extracts of ChoKalpha1 (52 KDa), ChoKbeta1(45 KDa), RhoA-QL(22 KDa), Cdc42-QL(25 KDa) and H-rasV12 (23 KDa). Empty vectors were used as controls for the endogenous levels, and GAPDH as loading control. B) and C)In vitro choline kinase activity of ChoKalpha1 or ChoKbeta1 in the presence of enhanced expression of constitutive active forms of RhoA, Cdc42 or H-Ras. D) and E)In vitro ethanolamine kinase activity of ChoKalpha or ChoKbeta in the presence of each indicated constitutive active form of GTPase. The results are represented as fold induction of conversion to the corresponding phosphorylated metabolite determined as total cpm/microg of whole cellular extract, and normalized to the empty vector transfected cells as control. Data shown represent the mean values+/-SEM of 3 independent experiments, each one performed with duplicate samples. Statistical significance (p</=0.05) is marked by an asterisk comparing to the activity achieved when ChoKalpha1 or ChoKbeta1, where appropriate, are transfected alone.
###end p 29
###begin title 30
Differential role between ChoK isoforms in cell transformation and tumorigenesis
###end title 30
###begin p 31
###xml 160 164 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 166 170 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina7">[36]</xref>
###xml 553 557 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 776 782 759 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g003">Fig. 3</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
The implication of ChoKalpha1 in cell transformation and human carcinogenesis has been extensively studied, and it has been shown to display oncogenic activity [15], [36]. Due to its extensive homology, we investigated if ChoKbeta could induce cellular transformation when overexpressed in non-tumorigenic cells. First, the ability of ChoKbeta-transfected cells to promote anchorage independent cell growth was determined using the cell line HEK293T. As previously reported, ChoKalpha1 induced a significant increase in the number of soft agar colonies [15]. By contrast, under similar conditions, ChoKbeta overexpression had no significant effect on the number nor the size of the colonies when compared to those generated by control, empty vector transfected HEK293T cells (Fig. 3). These results were confirmed using another non-tumorigenic cell line from a different species such as MDCK, obtaining similar results despite of the lower level of overexpression of both ChoK isoforms compared to the HEK293T cells. The differential level of expression obtained was due to the rather different efficiency in transfection for each cell lines (data not shown).
###end p 31
###begin title 32
Anchorage independent cell growth of ChoKalpha1- and beta1-overexpressing cells.
###end title 32
###begin p 33
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 7 9 7 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 9 17 9 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 131 133 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 160 162 160 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 348 350 348 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 355 357 355 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E)</bold>
A) and B)In vitro ChoK activity of cell-free extracts from transfected cells at the moment of plating, determined as conversion of 14C-labeled choline to PCho. C) Photographs of a representative experiment of the soft agar assay. A total of 105 cells were plated per 60-mm dish, and the number of colonies quantified after 5-8 weeks of incubation. D) and E) Computer based automatic quantification of the number of colonies, mean values+/-SEM is represented. The assay was performed 3 independent times with triplicate samples obtaining similar results. Statistical significance (p</=0.05) is marked by an asterisk.
###end p 33
###begin p 34
###xml 197 203 187 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g004">Fig. 4</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
The ability of ChoKbeta to induce tumour growth was also investigated. Both ChoKalpha1- and ChoKbeta-transfected HEK293T or MDCK cells were subcutaneously inoculated into athymic mice. As shown in Fig. 4, the overexpression of ChoKalpha1 was sufficient to induce tumour growth in immunosuppressed mice in the both cell systems analyzed. By contrast, cells overexpressing ChoKbeta were not able to induce tumor growth under similar conditions. As indicated above, comparison in tumor growth rates between both cell lines is related to the diverse efficiency of transfection, much higher in HEK293T (aproxm. 80-90%) than MDCK (aproxm. 15-20%). These results are in keeping with those obtained in the soft-agar experiments, and strongly indicate that overexpression of ChoKbeta is not sufficient to induce tumor growth under conditions where ChoKalpha1 does.
###end p 34
###begin title 35
###xml 80 89 <span type="species:ncbi:10090">nude mice</span>
Overexpression of ChoKbeta1 is not sufficient to induce tumor growth in athymic nude mice.
###end title 35
###begin p 36
###xml 111 113 111 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A)</bold>
###xml 118 120 118 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 269 271 269 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 276 278 276 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D)</bold>
###xml 411 413 404 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E)</bold>
###xml 418 420 411 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F)</bold>
###xml 479 480 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 568 569 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 556 572 549 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vol&#8202;=&#8202;[D * d<sup>2</sup>]/2</italic>
###xml 724 725 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 733 734 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 100 109 <span type="species:ncbi:10090">nude mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
Xenografts were established by s.c. injection of transfected HEK293T or MDCK cells in athymic nu/nu nude mice. A) and B) Western Blot analysis of ectopic expression of choline kinase isoforms in transfected HEK293T or MDCK cells, respectively, before mice inoculation. C) and D) Analysis of choline kinase activity in ChoKalpha1 or beta1 transfected HEK293T or MDCK cells-free extracts before mice inoculation. E) and F) Volume of tumors generated by subcutaneous injection of 106 transfected cells. Tumoral volume was calculated according to the formula: Vol = [D * d2]/2, where D and d are major and minor tumor diameters respectively. The data from HEK293T represents mean values+/-SEM from two independent experiments (n1 = 12; n2 = 16), the MDCK experiment correspond to an equivalent experiment with n = 12.
###end p 36
###begin title 37
###xml 50 57 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
ChoKbeta isoform shows preferential EtnK activity in vivo
###end title 37
###begin p 38
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 584 593 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g005">Figure 5A</xref>
###xml 941 950 913 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g005">Figure 5B</xref>
###xml 1071 1081 1043 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g005">Fig. 5C, D</xref>
###xml 1148 1158 1120 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g005">Fig. 5E, F</xref>
###xml 1267 1274 1239 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g005">Fig. 5G</xref>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 1028 1033 <span type="species:ncbi:9606">human</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
We next investigated if there was any difference in the enzymatic activity of both ChoK isoforms under in vivo conditions that could explain their differential biological activity. Thus, the activity of ChoKalpha1 and ChoKbeta as ChoK and/or EtnK in a whole-cell system was tested. Intracellular lipids of human HEK293T overexpressing ChoKalpha1, ChoKbeta or transfected with an empty vector, were extracted an analyzed. Both, the insoluble lipid fraction containing the hydrophobic lipids and total protein content were used as loading control obtaining similar results. As shown in Figure 5A, the intracellular phosphoethanolamine levels were increased to a similar extent in ChoKalpha1- or ChoKbeta-transfected cells. However, the intracellular phosphocholine levels of ChoKbeta-transfected cells were not significantly different to that of control cells, while ChoKalpha1-transfected cells showed an increased intracellular PCho levels (Figure 5B). Similar results were obtained using epithelial cells of different origins: human breast adenocarcinoma cells SK-Br-3 (Fig. 5C, D) or the human Non Small Cell Lung Cancer (NSCLC) cell line H1299 (Fig. 5E, F). In addition, in all cell lines analyzed, protein expression was also determined by Western Blot analysis (Fig. 5G).
###end p 38
###begin title 39
###xml 105 110 <span type="species:ncbi:9606">human</span>
Intracellular phosphocholine and phospoethanolamine levels after ChoKalpha1 or ChoKbeta1 transfection in human cells.
###end title 39
###begin p 40
###xml 164 170 157 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A), C)</bold>
###xml 175 177 168 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E)</bold>
###xml 315 321 301 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B), D)</bold>
###xml 326 328 312 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F)</bold>
###xml 471 473 450 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 484 486 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 539 560 518 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 860 862 835 837 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G)</bold>
###xml 87 92 <span type="species:ncbi:9606">human</span>
HEK293T, SK-Br-3 or H1299 cells were transfected with eukaryotic expression vectors of human ChoKalpha1 and ChoKbeta1 gene or pCDNA3b empty vector used as control. A), C) and E) Intracellular EtnK activity of choline kinase alpha1 and beta1 isoforms in whole cells in HEK293T, H1299 and SK-Br-3 cells respectively. B), D) and F) Intracellular ChoK activity of ChoKalpha and ChoKbeta isoforms in whole cells in HEK293T, H1299 and SK-Br-3 cells respectively. The amount of 14C-PCho and 14C-PEtn were extracted and quantified as described in Materials and Methods. The experiment was performed in triplicate samples, repeated 3 times, and mean values+/-SEM from all experiments estimated. Statistical significance (p</=0.05) is marked by an asterisk. A typical radio-labelling experiment results in about 70% of radioactive compound incorporation into the cells. G) Representative Western Blot of ectopic ChoKalpha1 or ChoKbeta1 expression in each cell line. Baseline values chosen as 1-fold in the graphs for each cell line represent: HEK293T cells (PCho: 1153 cpm; PEtn: 1231 cpm); H1299 cells (PCho: 22821 cpm; PEtn: 13339 cpm), and SK-Br-3 cells (PCho: 18620 cpm, PEtn: 3151 cpm).
###end p 40
###begin p 41
###xml 233 240 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 415 423 398 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 472 479 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Thus, the differential enzymatic activity of ChoKalpha1 and ChoKbeta found in HEK293T is not cell line specific. These results indicate that ChoKalpha1 but not ChoKbeta, is able to induce increased intracellular levels of PCho under in vivo conditions. However, under the same conditions both enzymes are able to generate phophorylethanolamine. Thus, even though ChoKbeta displays both ChoK and EtnK activity under in vitro conditions, it shows preferential EtnK activity in vivo.
###end p 41
###begin title 42
Increased levels of ChoKalpha mRNA but not ChoKbeta in tumor-derived cell lines
###end title 42
###begin p 43
###xml 690 696 676 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007819-g006">Fig. 6</xref>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 342 347 <span type="species:ncbi:9606">Human</span>
In order to further investigate the relevance of each ChoK isoenzyme in tumorogenesis, we determined the levels of both ChoKalpha and ChoKbeta mRNA in a panel of human tumour-derived cell lines by quantitative PCR technology. A panel of breast and lung cancer cell lines were compared with the primary, senescent, non-tumoral cell line HMEC (Human Mammary Epithelial Cells) or the immortalized, non-tumorogenic MCF10A cells as control breast cell lines, and primary Bronchial Epithelial Cells (BEC) as control lung cell line. All tumoral cell lines tested significantly overexpress ChoKalpha mRNA compared with the normal cell lines, whereas no changes were found for ChoKbeta mRNA levels (Fig. 6). These results indicate that ChoKbeta is not specifically upregulated in breast or lung cancer cells, suggesting that high levels of ChoKbeta are not required for the promotion of cancer.
###end p 43
###begin title 44
Comparative expression of ChoKalpha1 and ChoKbeta1 mRNA in a panel of cancer cell lines.
###end title 44
###begin p 45
###xml 385 398 385 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 425 427 417 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 486 491 <span type="species:ncbi:9606">Human</span>
Q-PCR was performed to determine the level of expression of mRNA in non-tumorogenic mammary cell lines (HMEC, MCF10A), breast cancer cell lines (MDA-MB435, MDA-MB468, T47D, MCF7), non-tumorogenic lung cells (BEC) and lung cancer cell lines (H510, H82). The data were normalized with the endogenous 18S ribosomal RNA. For the comparison between tumoral and non-tumoral cell lines, the 2-DeltaDeltaCt method was applied and log10 RQ is represented. Note that the data are referred to the Human Mammary Epithelial Cells (HMEC) mRNA levels in breast cell lines and no significant difference in the level of both ChoK isoforms mRNA was found with the normal MCF10A cell line. The reference for lung cancer cells was the primary Bronchial Epithelial Cells (BEC).
###end p 45
###begin title 46
MN58b is a specific inhibitor of ChoKalpha isoform
###end title 46
###begin p 47
###xml 151 154 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal1">[2]</xref>
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba1">[14]</xref>
###xml 162 166 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba2">[37]</xref>
###xml 284 291 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 361 365 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 367 371 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba2">[37]</xref>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
The implication of ChoKalpha in human carcinogenesis has been used for the design of specific inhibitors of this enzyme as a novel anticancer strategy [2], [14], [37]. MN58b is the leading compound to support this novel strategy since it has shown a potent antitumoral activity under in vivo conditions versus human colon, lung, breast and bladder tumor models [15], [37].
###end p 47
###begin p 48
###xml 101 104 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 678 686 657 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 775 777 754 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 930 932 905 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 970 972 938 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 610 615 <span type="species:ncbi:9606">human</span>
The primary structure of mammalian ChoKbeta displays an overall 60% homology with that of ChoKalpha1 [1]. The higher degree of homology lies within the choline/ethanolamine kinase domain. This homology could make it susceptible to a similar inhibition for both ChoKalpha1 and ChoKbeta with the same inhibitors. Thus, we have investigated the specificity of MN58b towards these two ChoK isoenzymes in order to verify if its antitumoral effect is specifically related to the inhibition of the alpha isoform, that is the one implicated in tumor progression, or the drug similarly affects both isoforms. Using the human ChoKalpha1 and ChoKbeta recombinant proteins, we performed an in vitro ChoK activity inhibition assay using increasing MN58b concentrations, determining the IC50 for each enzyme. As expected, despite the high similarity displayed between ChoK isoforms, MN58b showed a much higher specificity against ChoKalpha1 (IC50 = 5 microM) than against ChoKbeta (IC50 = 107.5 microM). Thus, MN58b is 21.5 times more potent against ChoKalpha1 than ChoKbeta isoform.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHKA</italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHKB</italic>
###xml 350 354 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHKA</italic>
###xml 470 474 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina1">[13]</xref>
###xml 476 480 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 482 486 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina3">[27]</xref>
###xml 488 492 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina4">[28]</xref>
###xml 494 498 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba2">[37]</xref>
###xml 500 504 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez2">[38]</xref>
###xml 506 510 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina8">[44]</xref>
###xml 651 655 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Eliyahu1">[21]</xref>
###xml 701 705 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Teichert1">[31]</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 673 678 <span type="species:ncbi:10090">mouse</span>
The family of human choline/ethanolamine kinases comprises two genes, CHKA and CHKB that codify for three enzymes, ChoKalpha1 (52 kDa), ChoKalpha2 (50 kDa) and ChoKbeta1 (45 kDa). ChoKalpha1 and ChoKalpha2 are almost identical, except for a stretch of 18 extra amino acids in ChoKalpha1, as they result from differential splicing from the same gene, CHKA. While the implication of ChoKalpha1 in the regulation of cell growth and cancer has been extensively demonstrated [13], [15], [27], [28], [37], [38], [44], preliminary evidence suggest that ChoKbeta may not be involved in carcinogenesis since it is not overexpressed in breast cancer cell lines [21] nor in the TRAMP mouse prostate cancer model [31].
###end p 50
###begin p 51
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lykidis1">[45]</xref>
###xml 292 295 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama1">[1]</xref>
###xml 297 300 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Uchida1">[3]</xref>
###xml 301 304 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama2">[5]</xref>
###xml 440 447 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 583 601 576 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tripanosoma brucei</italic>
###xml 611 613 604 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 651 653 644 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 701 709 694 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 709 713 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Gibellini1">[46]</xref>
###xml 853 857 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lykidis1">[45]</xref>
###xml 859 863 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Weinhold1">[47]</xref>
###xml 985 989 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Tijburg1">[48]</xref>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 769 775 <span type="species:ncbi:10090">murine</span>
###xml 892 898 <span type="species:ncbi:10090">murine</span>
A distinct human gene family has been described that codifies for EtnK activity [45], suggesting that EtnK1 is the main enzyme involved in PE homeostasis. The ChoK/EtnK domain confers to ChoKalpha and ChoKbeta the ability to function as both ChoK and EtnK activity under cell-free conditions [1], [3]-[5], but it is still unknown if these previously characterized enzymes showed any selectivity to each branch of the Kennedy pathway in the de novo synthesis of PC or PE. It has been recently described the different specificity towards Cho and Etn of the two isoforms of Cho/EtnK of Tripanosoma brucei. Whereas TbCho/Etn1 displays only EtnK activity, TbCho/Etn2 displays both ChoK and EtnK activities in vitro[46]. These results are in keeping with those described for murine EtnK1 that is Etn specific and EtnK2 that displays a dual ChoK/EtnK function [45], [47]. On the other hand, whereas murine Pcyt1alpha and Pcyt1beta are involved in PC biosynthesis, Pcyt2 is focused to PE only [48].
###end p 51
###begin p 52
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 754 758 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Sher1">[49]</xref>
###xml 760 764 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Wu1">[50]</xref>
###xml 790 793 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rmd</italic>
###xml 958 962 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Sher1">[49]</xref>
###xml 1125 1128 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1293 1300 1254 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1340 1347 1301 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1449 1452 1399 1402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 361 368 <span type="species:ncbi:562">E. coli</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
###xml 1629 1633 <span type="species:ncbi:10090">mice</span>
However, it is not yet fully understood which ChoK isoform, if any, contributes in vivo in each pathway to maintain the normal homeostasis of both PC and PE in biological membranes. The results shown here confirm that both enzymes have the ability to phosphorylate choline and ethanolamine under cell-free conditions, either as recombinant proteins produced in E. coli, or in cell extracts from mammalian cells. However, we found that under whole cell conditions ChoKalpha1 has the ability to function as both ChoK and EtnK, but ChoKbeta only affects the production of PEtn. These findings of different roles for alpha and beta isoforms are in keeping with the information from the recently generated Knock Out (KO) mice for ChoKalpha and ChoKbeta genes [49], [50]. Thus, ChoKbeta KO mice (rmd mice) are viable, but develop a rostrocaudal muscular dystrophy, while normal PC lipid levels are found in most tissues analyzed except in hindlimb skeletal muscle [49]. Therefore, ChoKalpha is sufficient to maintain normal PC levels in most tissues. By contrast, the lack of ChoKalpha results in embryonic lethality, and ChoKalpha+/- heterozygous mice display an accumulation of Cho and a reduction in PCho in liver and testis, suggesting that there is no ChoKbeta compensation for PC biosynthesis in vivo. These results suggest different roles in vivo for both ChoKalpha and ChoKbeta isoforms. Furthermore, the attenuated levels in PE found in ChoKalpha+/- heterozygous mice suggest the involvement of ChoKalpha not only in the biosynthesis of PC but also in the PE pathway. This is also consistent with the fact that in ChoKbeta KO mice, PE levels are unaffected, indicating that PE homeostasis is fully maintained with the EtnK1 and ChoKalpha proteins intact.
###end p 52
###begin p 53
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 319 322 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aoyama3">[8]</xref>
###xml 328 335 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 406 413 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
The group of Ishidate has provided valuable information about the in vitro activity of ChoK from different mouse tissues, and they have postulated that the most active form for choline kinase activity is the alpha/alpha homodimer followed by alpha/beta heterodimers, being the beta/beta homodimer the least active form [8]. The in vivo results shown here are partially in keeping with this hypothesis. The in vivo activity of ChoKbeta is focused in PE biosynthesis and displays higher Km for choline than ChoKalpha, this could be the reason why beta/beta dimers show low ChoK activity. When ChoKbeta was overexpressed we observed an increase in the intracellular levels of PEtn but not of PCho. However no differences were found between both isoforms for the generation of PEtn, since both display similar EtnK activity.
###end p 53
###begin p 54
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Cuadrado1">[12]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Aboagye1">[19]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Iorio1">[24]</xref>
###xml 311 315 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 417 421 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina3">[27]</xref>
###xml 423 427 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina4">[28]</xref>
###xml 849 858 <span type="species:ncbi:10090">nude mice</span>
PCho has been proposed to promote mitogenesis in mammalian cells [12]. In keeping with this, magnetic resonance spectroscopy techniques have revealed higher levels of phosphomonoesthers in tumoral samples when compared to their normal counterparts [19]-[24]. Moreover, overexpression of ChoKalpha1 is oncogenic [15], and enhanced ChoKalpha activity is a frequent feature in tumoral samples compared to normal tissues [27], [28]. Taken together all these results strongly indicate that ChoKalpha1 activity and PCho levels have a strong implication in cancer. Furthermore, overexpression of ChoKalpha1 results in an increase in EtnK activity and PEtn levels. However the latter effect by itself is not sufficient to induce cell transformation, since overexpression of ChoKbeta does not induce enhanced colony formation in soft-agar or tumor growth in nude mice. These results are consistent with the hypothesis that it is the production of PCho what is linked to cell proliferation and transformation mediated by ChoK, and that the production of PEtn may not be sufficient or relevant in this process.
###end p 54
###begin p 55
###xml 377 382 <span type="species:ncbi:9606">human</span>
The above results suggest that the two ChoK isoforms investigated, besides their similarity in their primary sequences, are implicated in different metabolic pathways. Thus while ChoKalpha1 impinges into both PC and PE synthesis, ChoKbeta affects only PE synthesis. Furthermore, the transformation capacity seems to be exclusive to the ChoKalpha isoform. However, since in the human HEK293T, Sk-Br-3 and H1299 cell lines, ChoKalpha1 overexpression produces elevated levels of both PCho and PEtn, while similar ChoKbeta overexpression results only in higher levels of PEtn but normal levels of PCho, we can not rule out the possibility that cell transformation requires both ChoK and EtnK activities.
###end p 55
###begin p 56
###xml 250 257 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 388 392 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-AlSaffar1">[51]</xref>
###xml 487 491 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez2">[38]</xref>
###xml 724 727 713 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Lacal1">[2]</xref>
###xml 880 884 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez2">[38]</xref>
###xml 885 889 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RodriguezGonzalez4">[40]</xref>
###xml 1107 1111 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina5">[29]</xref>
###xml 1155 1159 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
Consistent with the idea that links oncogenic activity to the function of ChoKalpha, but not ChoKbeta, the antiproliferative and antitumoral activity of MN58b was only associated to the activity of ChoKalpha. Furthermore, as previously reported, the in vivo treatment with MN58b results in a specific decrease of PCho levels in the tumours but no significant effect on the levels of PEtn [51]. Previous results from our group have demonstrated that MN58b also inhibits choline transport [38]. However this effect has a little influence in the antiproliferative and antitumoral activity of the drug since HC-3, a much more potent inhibitor of choline transporters, is far less potent as an antiproliferative agent than MN58b [2]. Furthermore, MN58b has a differential effect on either normal or tumor cells, a strong demonstration of a differential activity due to ChoK inhibition [38]-[40]. These results are also in keeping with the observation that ChoKalpha but not ChoKbeta is a downstream target of oncogenic molecules such as Ras and RhoA. Thus, while Ras activates ChoKalpha through Ral-GDS and PI3K [29], and RhoA activates ChoKalpha through ROCK [15], none of these oncogenic GTPases affect ChoKbeta activity under similar conditions. Again, these results indicate that although both ChoK enzymes are able to phosphorylate both choline and ethanolamine under cell-free systems conditions, they display different affinities for these substrates, and in whole-cell assays conditions they are governed by distinct regulatory pathways.
###end p 56
###begin p 57
###xml 378 382 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Eliyahu1">[21]</xref>
###xml 510 514 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina6">[30]</xref>
###xml 599 604 <span type="species:ncbi:9606">human</span>
Finally, the involvement of ChoKbeta in breast and lung cancer has been studied, ChoKalpha and beta mRNA levels were determined by Q-PCR. All tumour-derived cell lines assayed significantly overexpress ChoKalpha mRNA, while no changes were found in the expression of ChoKbeta. Similar results have been recently reported, using semi-quantitative PCR in breast cancer cell lines [21]. In addition, it has been recently described that elevated mRNA levels of ChoKalpha is a poor prognostic factor in lung cancer [30]. These results suggest that ChoKalpha but not ChoKbeta is playing a crucial role in human carcinogenesis.
###end p 57
###begin p 58
###xml 445 449 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-GallegoOrtega1">[52]</xref>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
The results shown here suggest that ChoKbeta and its produced metabolites are not implicated in human cell transformation. Therefore, all the efforts aimed at dilucidating the involvement of ChoK activity in the diagnosis, prognosis and treatment of cancer have to be focused in the ChoKalpha isoform. In keeping with this, recently the use of specific monoclonal anti-ChoKalpha antibodies has been proposed as a diagnostic tool in human cancer [52]. Furthermore, the newly designed antitumoral agents are expected to be more specific and hence less toxic than the actual drugs used in conventional chemotherapy. Due to the high structural homology displayed by both choline kinase proteins, the search for new anticancer agents based on their ability to interfere with ChoK activity, must exhibit stronger antiproliferative activity based on their specificity towards the ChoKalpha isoform.
###end p 58
###begin p 59
The lack of specific inhibition of ChoKbeta by these newly designed compounds represents a new feature to take into account for the chemical improvement of ChoKalpha inhibitors with potential antitumoral activity. Furthermore, non-specific drugs affecting ChoKbeta may result in a muscular disease produced by the lack of cell membrane lipid reparation in muscle tissue.
###end p 59
###begin p 60
###xml 367 371 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-BanezCoronel1">[53]</xref>
###xml 372 376 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Krishnamachary1">[55]</xref>
In addition, it has been recently demonstrated using a genetic approach that the specific inhibition of ChoKalpha by shRNA displays antiproliferative and antitumoral activity The high specificity of this technology provides definitive evidence of an antitumoral strategy based on ChoKalpha inhibition, supporting previous results with the pharmacological inhibitors. [53]-[55]
###end p 60
###begin p 61
###xml 193 200 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 232 237 <span type="species:ncbi:9606">human</span>
Thus, despite the high homology and similar activity displayed under cell-free conditions, ChoKalpha1 and ChoKbeta isoforms show a different substrate ability and behave very differently under in vivo conditions, suggesting that in human cells, ChoKbeta behaves as an EtnK and its overexpression is not able to induce higher intracellular levels of PCho. As a consequence, ChoKbeta has no effect on cell proliferation and does not contribute to oncogenic transformation. Finally, ChoKalpha but not ChoKbeta, should be used as the molecular target for the design of anticancer drugs aiming at interfering with choline kinase acitivity.
###end p 61
###begin title 62
Materials and Methods
###end title 62
###begin title 63
Ethics statement
###end title 63
###begin p 64
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 263 317 263 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Consejo Superior de Investigaciones Cientificas (CSIC)</italic>
All animals were handled in strict accordance with good animal practice as defined by the Guidelines of the Spanish Government (RD 223/1988, March 14th and RD 1201/2005 October 10th). The animal work has been conducted under the permission and supervision of the Consejo Superior de Investigaciones Cientificas (CSIC) Ethic Committee as approved in the context of the appropriate Research Project.
###end p 64
###begin title 65
Cell cultures and transfections
###end title 65
###begin p 66
###xml 106 107 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 448 452 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Montaner1">[56]</xref>
###xml 993 997 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Montaner2">[57]</xref>
###xml 1104 1108 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina5">[29]</xref>
###xml 114 119 <span type="species:ncbi:9606">Human</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
Cells were maintained under standard culture conditions of humidity (95%), temperature (37degreesC) and CO2 (5%). Human Embryonic Kidney (HEK293T), human breast adenocarcinoma (SK-Br-3) and Canine Kidney Madin-Darby (MDCK) cells were maintained in DMEM supplemented with 10% FBS, human non-small cell lung cancer cells H1299 were maintained in RPMI with 10% FBS. HEK293T transfections were performed using calcium phosphate as previously described [56]. MDCK, SK-Br-3 and H1299 cells were transfected using lipofectamine reagent (Invitrogen, CA) following manufacturers recommendations. Eukaryotic expression vectors encoding for human ChoKalpha1 and beta1 isoforms were pCDNA3b (Invitrogen, CA) and pLPneo (BD Biosciences Clontech, CA) respectively, both empty vectors were used as controls but only pCDNA3b is usually represented (data not shown). Constitutively activated expression pCDNA3b derivative vectors encoding for RhoA (QL), Rac1 (QL) and Cdc42 (QL) have been previously described [57]. Expression vector encoding to the constitutive active form of H-Ras (V12) have been previously described [29].
###end p 66
###begin title 67
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Choline kinase in vitro activity assays
###end title 67
###begin p 68
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba1">[14]</xref>
###xml 193 194 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 256 262 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">methyl</italic>
###xml 263 265 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 333 335 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
Eukaryotic cell extracts activity assays were carried out as previously described [14]. Cell extracts were incubated for 30 min at 37degreesC in a buffer containing 100 mM Tris pH 8, 10 mM MgCl2 and 10 mM ATP and 200 microM (55 mCi/nmol, 2 microCi/ml) of [methyl-14C] choline chloride (Amersham Biosciences, UK) for ChoK assay or 2-[14C]-ethan-1-ol-2-amine hydrochloride for EtnK assay (Amersham Biosciences).
###end p 68
###begin p 69
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 49 56 <span type="species:ncbi:562">E. coli</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
For Michaelis-Menten kinetics assay, extracts of E. coli expressing human ChoKalpha1 or ChoKbeta1 were used. A time course reaction was performed for each substrate, the reaction was stopped each 2 minutes and a logarithmic scale was represented to obtain the Km. Specific ChoK inhibitor MN58b was kindly provided by TCD Pharma SL (Madrid, Spain).
###end p 69
###begin title 70
Analysis of phosphocholine and phosphoethanolamine production in whole cells
###end title 70
###begin p 71
###xml 146 152 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">methyl</italic>
###xml 153 155 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 194 196 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 324 328 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-HernandezAlcoceba2">[37]</xref>
HEK293T, SK-Br-3 and H1299 cells were transfected as described above. After transfection, cells were labelled to equilibrium adding 1 microCi/ml [methyl-14C] choline chloride or 1 microCi/ml 2-[14C]-ethan-1-ol-2-amine hydrochloride to the culture media for 24 h. Samples were resolved and quantified as previously described [37]. Briefly, cells were rinsed with PBS and fixed with 16% ice-cold trichloroacetic acid (TCA). TCA-soluble material containing choline and phosphocholine was washed three times with four volumes of diethyleter, dryed under vacuum and resuspended in water. Samples were resolved by Thin Layer Chromatography (TLC) on 60A Silica gel plates (Whatman, NJ), using as liquid phase 0,9% NaCl: methanol: ammonium hydroxide (50:70:5; v/v/v). Radioactivity was automatically quantified by an electronic radiography system (Instantimager, CT). TCA insoluble material containing hydrophobic lipids was used as a loading control. The insoluble fraction was dissolved in 0,25N sodium hydroxide and total lipids were analyzed by scintillation counting.
###end p 71
###begin title 72
Anti-choline kinase beta1 serum
###end title 72
###begin p 73
###xml 126 142 119 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
###xml 392 399 <span type="species:ncbi:9986">rabbits</span>
###xml 411 417 <span type="species:ncbi:9986">rabbit</span>
###xml 475 481 <span type="species:ncbi:9986">rabbit</span>
Human ChoKbeta1 gene was cloned into a prokaryotic expression vector (pGEX-4T3) (GE healthcare, UK) and expressed in DH5alpha Escherichia coli. Recombinant ChoKbeta1 was then purified by the GST system (Amersham Bioscience) following manufacturer's recommendations. Purified ChoKbeta1 was mixed (1:1; v/v) with Freund's complete Adjuvant (Sigma-Aldrich, MO) and then injected i.m. into white rabbits (80 microg/rabbit). Booster injections were given every 2 weeks (60 microg/rabbit) and the sample resuspended with Freund's incomplete Adjuvant (Sigma-Aldrich) (1:1; v/v).
###end p 73
###begin title 74
Analysis of protein expression by Western blot
###end title 74
###begin p 75
###xml 178 182 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-GallegoOrtega1">[52]</xref>
Equal amounts of cell lysates were resolved by electrophoresis in a 10% SDS-PAGE. ChoKalpha expression levels were detected using monoclonal antibody AD3 as previously described [52]. ChoKbeta1 was detected using the polyclonal antiserum described above as primary antibody at a standard dilution of 1/5000. GTPases antibodies: RhoA (Santa Cruz Biotechnology, Germany), Rac1 (Upstate, NY), pan-Ras (Santa Cruz Biotechnology), Cdc42 (BD Biosciences, transduction labs) and GAPDH antibody (Chemicon International, CA) were used following manufacturers recommendations. HRP-conjugated secondary antibodies were from Santa Cruz Biotechnology. The specific binding was detected using the chemioluminiscence detection kit ECL (Amersham Bioscience) following the manufacturer indications.
###end p 75
###begin title 76
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Soft agar anchorage-independent growth and in vivo tumorigenic assays
###end title 76
###begin p 77
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-RamirezdeMolina2">[15]</xref>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 347 354 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nu/nu</italic>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">Mice</span>
Anchorage-independent growth assays were performed at 5-6 weeks of incubation in HEK293T and 6-10 weeks in MDCK, as previously described [15], plating 105 cells per 60-mm dish. Crystal violet staining was performed to enhance colony contrast. The number of colonies was automatically quantified by computer based image software (Image J). For the in vivo assays, cells were injected (106 cells per mouse flank) s.c. in nu/nu athymic mice. Mice were kept under standard laboratory conditions according to the guidelines of Spanish Government.
###end p 77
###begin title 78
Quantitative PCR
###end title 78
###begin p 79
###xml 1192 1194 1133 1135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
ChoKalpha1 or beta1 mRNA levels were quantified by real-time reverse transcriptase PCR. The RNA was extracted from the cell lines using QIAshredder following the RNeasy Mini kit (Qiagen, Inc.) according to the manufacturer's instructions. The amount of 0.9 microg of total RNA, in a final concentration of 10 ng/microl per reaction, was retro transcribed by High-Capacity cDNA Archive Kit (Applied Biosystems) to the cDNA preparation. The reverse transcription conditions were 25degreesC for 10 min and 37degreesC for 2 h. Then, each cDNA sample was analyzed in triplicate using the ABI PRISM 7700 Sequence Detector (PE Applied Biosystems). Real-time PCR was carried out using Taqman Universal PCR Master Mix (Applied Biosystems), containing ROX to normalize emissions. Primers used for amplification of ChoKalpha, ChoKbeta and 18S ribosomal RNA were purchased from Applied Biosystems as Taqman Gene Expression Assays (ChoKalpha1 ID: Hs00608045_m1, ChoKbeta1 ID: Hs01925200_s1 and 18S ribosomal RNA ID: Hs99999901_s1). For thermal cycling, the following conditions were applied: 10 min at 95degreesC and 40 cycles of 15 sec at 95degreesC and 1 min at 60degreesC. The data are presented as Log10 RQ (Relative Quantity).
###end p 79
###begin title 80
Statistical analysis
###end title 80
###begin p 81
###xml 497 510 495 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 518 522 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007819-Livak1">[58]</xref>
Mean comparisons of ChoK activity or in-cell PCho increase between different groups were performed. Continuous variables with normal distribution were compared by T-test and non-normal distribution variables were compared by means of the Kruskal Wallis and Mann-Whitney U tests. Statistical significance was defined as p</=0.05. The statistical analyses were performed using SPSS software, version 13.0 (Inc, Chicago, Illinois). The method used to analyze data from real-time PCR experiments was 2-DeltaDeltaCt method [58], comparing the relative gene expression between normal and tumoral cell lines normalized to 18S ribosomal RNA as endogenous reference gene.
###end p 81
###begin p 82
###xml 77 82 <span type="species:ncbi:9606">human</span>
We thank Dr. Leonardo Brizuela and Dr. Jaehong Park for kindly providing the human ChoKbeta gene and Elena Bogonez ( Centro de Investigaciones Biologicas, Madrid) for her technical advices in Km determination. DGO is a fellow from Comunidad de Madrid/FPI 2004.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Structure and function of choline kinase isoforms in mammalian cells.
###end article-title 84
###begin article-title 85
Choline kinase: a novel target for antitumor drugs.
###end article-title 85
###begin article-title 86
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
Molecular cloning, characterization, and expression in Escherichia coli of a cDNA encoding mammalian choline kinase.
###end article-title 86
###begin article-title 87
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Purification and characterization of choline/ethanolamine kinase from rat liver.
###end article-title 87
###begin article-title 88
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Molecular cloning of mouse choline kinase and choline/ethanolamine kinase: their sequence comparison to the respective rat homologs.
###end article-title 88
###begin article-title 89
###xml 15 20 <span type="species:ncbi:9606">human</span>
Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine.
###end article-title 89
###begin article-title 90
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response.
###end article-title 90
###begin article-title 91
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
Expression and characterization of the active molecular forms of choline/ethanolamine kinase-alpha and -beta in mouse tissues, including carbon tetrachloride-induced liver.
###end article-title 91
###begin article-title 92
Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells.
###end article-title 92
###begin article-title 93
###xml 36 50 <span type="species:ncbi:8355">Xenopus laevis</span>
Phospholipase-induced maturation of Xenopus laevis oocytes: mitogenic activity of generated metabolites.
###end article-title 93
###begin article-title 94
Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
###end article-title 94
###begin article-title 95
Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.
###end article-title 95
###begin article-title 96
###xml 85 90 <span type="species:ncbi:9606">human</span>
Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression.
###end article-title 96
###begin article-title 97
Choline kinase inhibitors as a novel approach for antiproliferative drug design.
###end article-title 97
###begin article-title 98
Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.
###end article-title 98
###begin article-title 99
Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene.
###end article-title 99
###begin article-title 100
Metabolic profiles of cancer cells.
###end article-title 100
###begin article-title 101
###xml 11 16 <span type="species:ncbi:9606">human</span>
Studies of human tumors by MRS: a review.
###end article-title 101
###begin article-title 102
###xml 76 81 <span type="species:ncbi:9606">human</span>
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.
###end article-title 102
###begin article-title 103
###xml 30 35 <span type="species:ncbi:9606">human</span>
Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.
###end article-title 103
###begin article-title 104
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies.
###end article-title 104
###begin article-title 105
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
###end article-title 105
###begin article-title 106
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.
###end article-title 106
###begin article-title 107
Alterations of choline phospholipid metabolism in ovarian tumor progression.
###end article-title 107
###begin article-title 108
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
###end article-title 108
###begin article-title 109
###xml 60 65 <span type="species:ncbi:9606">human</span>
Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours.
###end article-title 109
###begin article-title 110
###xml 37 42 <span type="species:ncbi:9606">human</span>
Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
###end article-title 110
###begin article-title 111
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 127 132 <span type="species:ncbi:9606">human</span>
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.
###end article-title 111
###begin article-title 112
Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
###end article-title 112
###begin article-title 113
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.
###end article-title 113
###begin article-title 114
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) Tissue by (1)H-NMR analysis: evidence for unusual phospholipid metabolism.
###end article-title 114
###begin article-title 115
Rho GTPase expression in tumourigenesis: evidence for a significant link.
###end article-title 115
###begin article-title 116
The role of Rho GTPases in disease development.
###end article-title 116
###begin article-title 117
Rho GTPases: potential candidates for anticancer therapy.
###end article-title 117
###begin article-title 118
Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors.
###end article-title 118
###begin article-title 119
From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design.
###end article-title 119
###begin article-title 120
In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
###end article-title 120
###begin article-title 121
Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells.
###end article-title 121
###begin article-title 122
Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism.
###end article-title 122
###begin article-title 123
Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.
###end article-title 123
###begin article-title 124
###xml 72 75 <span type="species:ncbi:10116">rat</span>
###xml 179 182 <span type="species:ncbi:10116">rat</span>
Complete co-purification of choline kinase and ethanolamine kinase from rat kidney and immunological evidence for both kinase activities residing on the same enzyme protein(s) in rat tissues.
###end article-title 124
###begin article-title 125
###xml 45 48 <span type="species:ncbi:10116">rat</span>
###xml 75 81 <span type="species:ncbi:9986">rabbit</span>
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Complete purification of choline kinase from rat kidney and preparation of rabbit antibody against rat kidney choline kinase.
###end article-title 125
###begin article-title 126
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Purification and properties of choline kinase from rat brain.
###end article-title 126
###begin article-title 127
Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.
###end article-title 127
###begin article-title 128
Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway.
###end article-title 128
###begin article-title 129
###xml 76 94 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Biochemical characterisation of the initial steps of the kennedy pathway in Trypanosoma brucei - the ethanolamine and choline kinases.
###end article-title 129
###begin article-title 130
###xml 98 101 <span type="species:ncbi:10116">rat</span>
The separation, purification, and characterization of ethanolamine kinase and choline kinase from rat liver.
###end article-title 130
###begin article-title 131
Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine in the liver.
###end article-title 131
###begin article-title 132
A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis.
###end article-title 132
###begin article-title 133
Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis.
###end article-title 133
###begin article-title 134
###xml 110 115 <span type="species:ncbi:9606">human</span>
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
###end article-title 134
###begin article-title 135
Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer.
###end article-title 135
###begin article-title 136
Choline kinase alpha depletion selectively kills tumoral cells.
###end article-title 136
###begin article-title 137
RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
###end article-title 137
###begin article-title 138
###xml 75 80 <span type="species:ncbi:9606">human</span>
Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
###end article-title 138
###begin article-title 139
Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors.
###end article-title 139
###begin article-title 140
Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases.
###end article-title 140
###begin article-title 141
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been supported by grants to JCL from Comunidad de Madrid (GR-SAL-0821-2004), Ministerio de Ciencia e Innovacion (SAF2008-03750, RD06/0020/0016), Fundacion Mutua Madrilena, and by a grant to ARM from Fundacion Mutua Madrilena. DGO was a fellow from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 143

